Mary Gunn

Mary Gunn

Director de Operaciones en
Health Decisions, Inc.
.

Fortuna: 21 136 $ al 31/05/2026

Consumer Services
Commercial Services
Health Technology

Perfil

Mary Gunn is currently an Independent Director at Welwaze Medical, Inc. and Burst Diagnostics.
Since 2020, Dr. Gunn has been the Chief Operating Officer at Health Decisions, Inc. Formerly, Dr. Gunn was the Chief Executive Officer at Emerald Clinical Trials Pty Ltd. and served as an Independent Non-Executive Director at Edinburgh Worldwide Investment Trust Plc from 2023 to 2026.
Dr. Gunn completed undergraduate and MBA degrees at Brown University and earned a doctorate from Grand Canyon University.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
31/10/2025 5.610 ( 0 % ) 21 136 $ 31/05/2026

Cargos activos de Mary Gunn

EmpresasCargoInicio
Director de Operaciones 01/07/2020
Director/Miembro de la Junta -
Director/Miembro de la Junta -

Antiguos cargos conocidos de Mary Gunn.

EmpresasCargoFin
EDINBURGH WORLDWIDE INVESTMENT TRUST PLC Director/Miembro de la Junta 30/04/2026
Director Ejecutivo -
Ver el detalle de la experiencia de Mary Gunn.

Formación de Mary Gunn.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

10

Relaciones de 1er grado

8

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas8

Consumer Services

Miscellaneous

Consumer Services

Consumer Services

Commercial Services

Commercial Services

Health Technology

Health Technology